Form 4: Editas Medicine CEO Sells Shares to Cover Tax Obligations

Editas Medicine CEO Gilmore O'Neill sold 12,191 shares of common stock on June 4, 2024, at a price of $5.4956 per share to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On June 4, 2024, Gilmore O'Neill, CEO of Editas Medicine, Inc., sold 12,191 shares of common stock.
• The sale was executed at a price of $5.4956 per share.
• The transaction was conducted to meet tax withholding obligations resulting from the vesting of restricted stock units on June 2, 2024.
• The sale was executed under a pre-arranged automatic sales plan adopted on April 13, 2022, and does not represent a discretionary trade by the CEO.
• Following the transaction, O'Neill directly owns 315,279 shares of Editas Medicine common stock.

Sentiment

Score: 6

Explanation: The document reports a routine stock sale to cover tax obligations, which is neither particularly positive nor negative. The sale was pre-planned, reducing any potential negative sentiment.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally viewed as routine transactions.

Stakeholder Impact

• The sale of shares by the CEO could have a minor, temporary impact on the stock price, but is unlikely to be significant given the routine nature of the transaction.

Key Dates